口蹄疫市场规模、份额及成长分析（按疫苗类型、动物类型、通路和地区）－2025-2032 年产业预测

2023 年口蹄疫市场规模价值 32 亿美元，预计将从 2024 年的 34.8 亿美元成长到 2032 年的 68.4 亿美元，预测期间（2025-2032 年）的复合年增长率为 8.8%。

全球兽用疫苗市场，尤其是口蹄疫（FMD）疫苗市场，由于畜产品消费量的增加和牲畜数量的增加而经历显着增长。由于环境变化和全球化，牲畜传染病和通用感染疾病的出现促使世界各国政府对牲畜和家畜实施严格的卫生措施。这些日益增长的担忧反映在旨在防止可能对国家经济造成严重后果的通用感染疾病爆发的法律规范中。由于对牛奶、鸡蛋和肉类等产品的需求不断增长，投资也随之增加，因此，口蹄疫疫苗接种对于减轻潜在疫情造成的经济损失至关重要。然而，北美和欧洲等地区透过严格的动物移动控制有效控制了口蹄疫疫情，并减少了疫苗接种的需求。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

口蹄疫市场规模（按疫苗类型和复合年增长率） (2025-2032)

• 市场概览
• 常规疫苗
  • 氢氧化铝和皂素疫苗
  • 石油基疫苗
• 紧急疫苗

口蹄疫市场规模（按动物类型和复合年增长率）（2025-2032）

• 市场概览
• 牛
• 绵羊和山羊
• 猪
• 其他动物

FMD 市场规模（依分销管道划分）及复合年增长率（2025-2032 年）

• 市场概览
• 兽医诊所
• 政府
• 零售药局
• 网路药局

口蹄疫市场规模：依地区及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Boehringer Ingelheim（Germany）
• Merck Animal Health（USA）
• Zoetis（USA）
• MSD Animal Health（USA）
• Elanco Animal Health（USA）
• Ceva Sante Animale（France）
• Virbac（France）
• Indian Immunologicals Limited（India）
• Biogenesis Bago（Argentina）
• FMD Center World Reference Laboratory（UK）
• TAD Pharma GmbH（Germany）
• Vetoquinol（France）
• Phibro Animal Health Corporation（USA）
• Tiankang Bio（China）
• Ringpu Biology（China）
• CAVAC（China）
• Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna（Italy）
• Korea Animal Health Products Association（Korea）
• CZ Veterinaria（Spain）

结论和建议

FMD Disease Market size was valued at USD 3.2 billion in 2023 and is poised to grow from USD 3.48 billion in 2024 to USD 6.84 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global veterinary vaccine market, particularly for Foot-and-Mouth Disease (FMD) vaccines, is witnessing significant growth driven by increased animal product consumption and rising livestock populations. The emergence of livestock and zoonotic diseases, exacerbated by environmental changes and globalization, has prompted governments worldwide to implement stringent health measures for both domestic and livestock animals. This growing concern is reflected in regulatory frameworks aimed at preventing zoonotic outbreaks, which could severely impact national economies. With rising investments due to heightened demand for products like milk, eggs, and meat, the necessity for FMD vaccinations becomes paramount to mitigate financial losses from potential outbreaks. However, regions like North America and Europe have effectively controlled FMD incidents, reducing vaccination needs through strict animal movement regulations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fmd Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fmd Disease Market Segments Analysis

Global FMD Disease Market is segmented by Vaccine Type, Animal Type, Distribution Channel and region. Based on Vaccine Type, the market is segmented into Conventional vaccines and Emergency vaccines. Based on Animal Type, the market is segmented into Cattle, Sheep & goat, Pig and Other animals. Based on Distribution Channel, the market is segmented into Veterinary hospitals & clinics, Government institutions, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fmd Disease Market

The increasing demand for animal protein and dairy products significantly drives the FMD market, as foot-and-mouth disease (FMD) can lead to substantial economic losses within the livestock sector. As consumer preferences pivot towards animal-based nutrition, the necessity to maintain healthy livestock becomes crucial. Outbreaks of FMD can disrupt supply chains, result in culling, and diminish herd productivity, leading to increased urgency for effective vaccines and management strategies. Thus, addressing both FMD outbreaks and the rising demand for livestock products is essential for ensuring food security and stability in the agricultural economy, making it a pivotal factor influencing the FMD market.

Restraints in the Fmd Disease Market

The significant expense associated with FMD vaccines and diagnostic tests poses a considerable limitation on the Foot-and-Mouth Disease (FMD) market, especially in developing nations that boast substantial livestock populations. This financial burden restricts access to essential preventive measures and diagnostic tools, hindering effective management and control of the disease in regions where it is most needed. Consequently, the high costs can deter farmers and livestock owners from investing in vaccination programs, thereby increasing the vulnerability of their herds to outbreaks. As a result, the overall progress in mitigating FMD risks is adversely affected, compromising animal health and agricultural productivity.

Market Trends of the Fmd Disease Market

The FMD (Foot-and-Mouth Disease) market is witnessing a notable trend marked by a surge in demand for vaccines, primarily fueled by heightened awareness and proactive measures taken by governments in developing countries. As these nations strive to combat FMD outbreaks that threaten livestock health and agricultural productivity, investment in vaccination programs has intensified. Additionally, the rise in livestock trade and export activities amplifies the need for effective vaccination strategies, thereby driving market growth. Pharmaceutical companies are responding with innovative vaccine formulations and expanded production capacities, creating a dynamic landscape poised for substantial advancements in FMD prevention and control.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global FMD Disease Market Size by Vaccine Type & CAGR (2025-2032)

• Market Overview
• Conventional vaccines
  • Aluminium hydroxide & saponin-based vaccines
  • Oil-based vaccines
• Emergency vaccines

Global FMD Disease Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Cattle
• Sheep & goat
• Pig
• Other animals

Global FMD Disease Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Veterinary hospitals & clinics
• Government institutions
• Retail pharmacies
• Online pharmacies

Global FMD Disease Market Size & CAGR (2025-2032)

• North America (Vaccine Type, Animal Type, Distribution Channel)
  • US
  • Canada
• Europe (Vaccine Type, Animal Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Animal Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Animal Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Animal Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago (Argentina)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMD Center World Reference Laboratory (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TAD Pharma GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tiankang Bio (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ringpu Biology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CAVAC (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Korea Animal Health Products Association (Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CZ Veterinaria (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations